Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZQ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,888
Award facts
- Contract value 100% obligated
- $60,887.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $60,887.85, awards AmerisourceBergen Drug Corp with the supply of Cosentyx (secukinumab) 300mg dose in 2-pen vials for the Defense Logistics Agency (DLA). The contract represents a firm fixed-price, competitively awarded transaction with no set-aside designation and a completion date of January 12, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at up to $999,999,999.00 through December 2031 that provides a flexible vehicle for delivering medications and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA supply chain. The company's portfolio encompasses a wide range of therapeutic products including specialty medications, brand-name and generic drugs, vaccines, and medical devices. As a major pharmaceutical distributor headquartered in Pennsylvania and registered in the System for Award Management, the company consistently fulfills federal procurement requirements through competitive bidding, demonstrating its capability to meet the medical supply needs of government healthcare systems across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F0ZQ5?
SPE2DR26F0ZQ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F0ZQ5 worth?
The government has obligated $60,888 on SPE2DR26F0ZQ5.
Is contract SPE2DR26F0ZQ5 an order under another contract?
Yes. SPE2DR26F0ZQ5 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZQ5 competed?
The extent of competition for SPE2DR26F0ZQ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award